Medicare Colonoscopy Coverage: 2026 Costs & Rules Guide

Medicare colonoscopy coverage is one of the most generous benefits in the entire program — and one of the most misunderstood. A screening colonoscopy is completely free under Medicare Part B: no deductible, no coinsurance, no copay. Yet every year, beneficiaries open bills they didn’t expect after a “free” colonoscopy, skip screening because they fear the cost, or pay charges that federal law says they shouldn’t owe. The rules changed significantly in 2023 and again in 2025, and much of what you may have heard — including from billing offices — is out of date.

This guide walks through every colorectal cancer screening test Medicare covers, exactly what “free” does and doesn’t include in 2026, the polyp-removal coinsurance that is being phased out by law, the follow-up colonoscopy rule that eliminated the old Cologuard trap, and the billing errors worth catching. If you’ve already been diagnosed with colorectal cancer, our colorectal cancer coverage guide covers surgery, chemotherapy, and treatment costs; this article is for the far larger group — everyone else, because colorectal cancer screening applies to essentially every Medicare beneficiary.

Why This Is Medicare’s Most Valuable Free Benefit

Colorectal cancer is the second leading cause of cancer death in the United States, and more than half of new diagnoses occur after age 65. It is also among the most preventable major cancers, for one reason: it announces itself in advance. Nearly all colorectal cancers begin as polyps — small growths that take roughly 10 years, on average, to turn malignant. A colonoscopy doesn’t just detect cancer; it prevents it, because the physician removes polyps during the same procedure, years before they become dangerous.

That’s the math behind Medicare’s decision to make screening free. Caught at a localized stage, colorectal cancer has a five-year survival rate above 90 percent. Caught late, treatment involves surgery, months of chemotherapy, and some of the most expensive biologics in oncology — see our cancer treatment coverage guide for what that pathway costs. A free screening test that prevents that pathway entirely is, dollar for dollar, the best benefit in the program. Roughly one in three age-eligible Americans is still not up to date on screening — often because of cost fears this article should put to rest.

The Six Screening Tests Medicare Covers

Medicare covers a full menu of colorectal cancer screening options under Part B, all with zero cost-sharing when performed as screening:

A few details worth knowing:

Colonoscopy has no age limits under Medicare. Unlike Cologuard and blood tests, which are covered for ages 45–85, the screening colonoscopy benefit has no minimum or maximum age. Whether continued screening makes sense past your mid-70s is a conversation with your doctor about health status and life expectancy — but Medicare will not be the obstacle.

“High risk” means every 2 years, not every 10. You qualify for the 24-month interval if you have a personal history of colorectal cancer or adenomatous polyps, a first-degree relative (parent, sibling, child) with colorectal cancer or adenomatous polyps, inflammatory bowel disease (Crohn’s disease or ulcerative colitis), or a hereditary syndrome such as Lynch syndrome or familial adenomatous polyposis. This matters more than most people realize: once you’ve had precancerous polyps removed, all your future surveillance colonoscopies are billed as high-risk screening — still free — not as diagnostic procedures. Type 2 diabetes and obesity also raise colorectal cancer risk meaningfully, though they don’t change Medicare’s screening interval on their own.

CT colonography is the newest option. Medicare began covering virtual colonoscopy — a CT scan of the colon, no sedation required — on January 1, 2025, at the same $0 screening cost-sharing. The catch: bowel prep is still required, and if the scan finds a polyp, you need a real colonoscopy to remove it.

The blood test is real, but know its limits. Shield, approved by the FDA in 2024, screens for colorectal cancer from a routine blood draw and is covered every 3 years. It’s dramatically better than not screening at all, but it detects established cancers far better than precancerous polyps — so it prevents less cancer than colonoscopy does. It’s a reasonable choice for people who decline every other option.

What “Free” Includes — and the Bills That Can Still Arrive

Here’s where beneficiaries get surprised. The screening colonoscopy itself — gastroenterologist fee, facility fee — is fully covered with no deductible and no coinsurance. But four related charges follow their own rules.

1. Polyp removal: 15% coinsurance in 2026, falling to zero by 2030

For years, the “polyp billing trap” was the biggest complaint in Medicare screening: if the doctor found and removed a polyp during your free screening colonoscopy, the whole procedure was rebilled as diagnostic, and you suddenly owed the Part B deductible plus 20 percent coinsurance.

Congress fixed this in the Consolidated Appropriations Act, and the fix is phasing in on a fixed legal schedule. When a screening colonoscopy becomes therapeutic because polyps are removed:

• The Part B deductible is permanently waived — you never pay the $283 deductible on a screening that converted.
• Coinsurance is 15 percent in 2026 (it has been since 2023), drops to 10 percent in 2027–2029, and reaches zero in 2030.

In practical terms: if polyps are removed at an ambulatory surgery center, your 15 percent share of the physician and facility fees typically lands in the $80–$200 range in 2026; at a hospital outpatient department, more like $150–$350 for the identical procedure — the setting’s price difference flows straight through to your coinsurance. A Medigap plan pays this coinsurance in full, which is why people with Plan G genuinely pay $0 regardless of what the scope finds.

Keep perspective: polyps are found in 30 to 40 percent of screening colonoscopies in the Medicare age group, and removal is the entire point — it’s the cancer prevention. A possible $100–$300 bill is not a reason to skip the test. But it is a reason to know the rule, because…

2. Anesthesia: should be $0 — check your bill

Since January 1, 2015, Medicare has waived both the deductible and coinsurance for anesthesia furnished with a screening colonoscopy. And when the screening converts because polyps are removed, the anesthesia claim (billed with the “PT” modifier) still carries no deductible and no coinsurance. Sedation for a screening colonoscopy should cost you nothing — period.

This is also one of the most commonly misbilled services in Medicare. If you receive an anesthesia bill after a screening colonoscopy, don’t pay it reflexively. Call the billing office and ask whether the claim was submitted with the screening modifier (modifier 33 for a pure screening, PT for a screening that converted). A one-character billing code is frequently the entire difference between $0 and a $150–$400 anesthesia bill.

3. Pathology: the one small bill that’s usually legitimate

If polyps are removed, they’re sent to a pathologist, whose analysis is billed separately and may carry standard Part B cost-sharing. This is typically modest — often $20–$60 per specimen in coinsurance — and Medigap covers it. It’s worth knowing about only so a small lab bill doesn’t alarm you.

4. Bowel prep: covered under Part D, not Part B

The prep — the gallon jug or low-volume prescription kit you drink the night before — is a prescription drug, so it falls under Part D, not the free screening benefit. Generic 4-liter preps (PEG-3350 with electrolytes) are on nearly every formulary at low copays, often $0–$10. Newer low-volume branded preps (Suprep, Clenpiq, Sutab) may sit on higher tiers with $40–$100 copays, or require you to try the generic first. Over-the-counter regimens (Miralax plus Gatorade) aren’t covered by either part — though at $10–$20 cash, they’re often the cheapest route anyway. If prep cost is a barrier, ask your gastroenterologist’s office to prescribe whatever is cheapest on your specific plan; they handle this question daily. For more on how Medicare splits drug coverage, see Part B vs. Part D drugs.

The Follow-Up Colonoscopy Rule: The Old Cologuard Trap Is Closed

Until 2023, the stool-test pathway had a costly flaw. Cologuard or FIT was free — but if the result came back positive, the colonoscopy you then needed was billed as diagnostic, with full deductible and 20 percent coinsurance. Beneficiaries were effectively penalized for choosing the noninvasive test first, and some delayed the follow-up colonoscopy for exactly that reason — the most dangerous possible outcome of a positive screening result.

Since January 1, 2023, that trap no longer exists. CMS now defines the follow-up colonoscopy after a positive noninvasive stool test as the completion of the same screening — billed with a special modifier (KX), with no deductible and no coinsurance. In 2025, CMS extended the same protection to follow-up colonoscopies after a positive blood-based screening test. The complete screening — stool or blood test plus any follow-up colonoscopy it triggers — is one free benefit from start to finish.

Two caveats. First, if polyps are removed during that follow-up colonoscopy, the same 15 percent phase-down coinsurance described above applies — deductible still waived. Second, billing offices got this wrong regularly in the first years of the rule. If you’re charged full diagnostic cost-sharing for a colonoscopy that followed a positive Cologuard, FIT, or Shield result, appeal it — the claim likely just lacks the KX modifier.

One practical note: about 10 to 13 percent of Cologuard tests come back positive, and most positives are not cancer — they’re usually polyps or nothing at all. A positive stool test is a reason to schedule the colonoscopy promptly, not to panic.

Screening vs. Diagnostic vs. Surveillance: The Three Billing Lanes

Whether your colonoscopy is free depends entirely on which lane it’s billed in — and the lane is set before the scope ever starts.

Screening — you have no symptoms; it’s a routine interval test. Free, with the polyp-conversion rules above. This includes high-risk screening every 24 months.

Surveillance — you had polyps before, and you’re back on the recommended interval (often 3–5 years after adenomas, per your gastroenterologist; Medicare covers as often as every 24 months for high-risk beneficiaries). Under Medicare, surveillance is billed as high-risk screening — free. This is genuinely better than many commercial plans, which treat surveillance as diagnostic.

Diagnostic — you have symptoms: rectal bleeding, unexplained anemia, a change in bowel habits, abdominal pain, weight loss. This is not a preventive service. You pay the Part B deductible ($283 in 2026) plus 20 percent coinsurance on the physician, facility, anesthesia, and pathology fees. Total out-of-pocket without supplemental coverage typically runs $250–$500 at an ambulatory surgery center and $450–$900 at a hospital outpatient department — the same setting-based price spread that applies across outpatient procedures, and worth asking about when you schedule. What Medicare Part B covers explains the outpatient cost structure in detail.

Be straightforward with your doctor about symptoms — never minimize rectal bleeding to keep a colonoscopy “billed as screening.” A diagnostic workup exists to find problems while they’re still small, and the cost difference is trivial compared to a late-stage diagnosis.

If a colonoscopy leads to a serious complication requiring admission — perforation occurs in roughly 1 in 2,000 procedures — the hospitalization falls under Part A with its own deductible. Rare, but it’s the honest fine print.

What You’ll Pay: Cost Summary

With Medigap Plan G, every coinsurance amount in that table drops to $0 (the Part B deductible still applies to diagnostic procedures). Our Medigap vs. Medicare Advantage cost comparison shows how this plays out across full health scenarios. For beneficiaries with limited income, Medicare Savings Programs can eliminate Part B cost-sharing entirely.

Medicare Advantage: Same Free Screening, Different Fine Print

Medicare Advantage plans are required to cover screening colonoscopies — including the polyp-conversion and follow-up-colonoscopy protections — at the same $0 cost-sharing as Original Medicare. The differences show up around the edges:

• Network: the gastroenterologist, the facility, the anesthesiologist, and the pathologist must all be in-network to guarantee $0. An out-of-network anesthesiologist at an in-network facility is a classic source of surprise bills in HMO plans.
• Referrals: HMO plans may require a primary care referral to see a gastroenterologist, even for screening.
• Diagnostic and surveillance cost-sharing varies by plan — some MA plans charge facility copays ($150–$400) for diagnostic colonoscopies that would cost less under Original Medicare with Medigap.
• Prior authorization generally doesn’t apply to routine screening but may apply to diagnostic procedures and repeat surveillance.

None of this should discourage screening in an MA plan — the core benefit is identical and free. It just means one extra phone call to confirm everyone involved is in-network.

Colonoscopy or Cologuard? A Practical Framework

Both are free, so cost shouldn’t drive the choice. The clinical trade-off:

Choose colonoscopy if you can. It’s the only test that prevents cancer rather than detecting it, it’s the only option if you’re high-risk, and a clean result buys you 10 years. Cologuard detects about 92 percent of cancers but misses more than half of advanced precancerous polyps — the things colonoscopy would have removed on the spot.

Choose Cologuard or FIT if you won’t get a colonoscopy. The best screening test is the one that actually happens. If prep, sedation, or a day off work means you’d otherwise skip screening altogether, a stool test every 1–3 years is a genuinely good option — and thanks to the 2023 rule, a positive result leads to a free colonoscopy, not a bill.

The blood test is the fallback, not the first choice — better than nothing, weakest at catching precancerous disease.

Seven Steps to a $0 Colonoscopy

1. Confirm your interval. Ask your doctor whether you’re average-risk (10 years) or high-risk (24 months), and when your last screening was. Medicare denies screenings billed too early.
2. Say the word “screening” when you schedule, and confirm the office is billing it as preventive. If you’ve had a positive stool test, tell them — the follow-up must be billed with the KX modifier to be free.
3. Ask about the setting. An ambulatory surgery center means lower coinsurance than a hospital outpatient department if polyps are removed — and a lower bill if anything is billed diagnostically.
4. In Medicare Advantage, verify the whole team is in-network — facility, gastroenterologist, anesthesia, and pathology.
5. Ask for the cheapest covered prep on your Part D formulary; generic PEG-3350 preps are nearly always low-copay.
6. Don’t pay surprise bills without checking. Anesthesia bills after screening colonoscopies and diagnostic-rate bills after positive stool tests are the two most common errors — both are usually fixed by resubmitting with the right modifier.
7. Keep your pathology report. If adenomas were found, you’re now high-risk — future colonoscopies are covered every 24 months at $0, and your recommended surveillance interval drives when you go back.

Frequently Asked Questions

Is a colonoscopy free under Medicare? Yes — a screening colonoscopy is covered under Part B with no deductible and no coinsurance, at any age, every 10 years (every 24 months if you’re high-risk). If polyps are removed, you pay 15 percent coinsurance in 2026 (no deductible), an amount that drops to zero by 2030.

Does Medicare pay for a colonoscopy after a positive Cologuard test? Yes, at $0. Since January 1, 2023, the follow-up colonoscopy after a positive stool test is billed as part of the same free screening — not as a diagnostic procedure. If you’re charged, ask the billing office to resubmit the claim with the KX modifier.

Why did I get an anesthesia bill for my free colonoscopy? Probably a billing error. Medicare waives both deductible and coinsurance for anesthesia with a screening colonoscopy — even when polyps are removed. Ask whether the anesthesia claim included modifier 33 (screening) or PT (screening converted); correctly coded, it costs you $0.

How often will Medicare pay for a colonoscopy after polyps? Once you’ve had adenomatous polyps, you’re high-risk, and Medicare covers screening colonoscopies every 24 months at no cost. Your gastroenterologist will recommend an interval — commonly 3 to 5 years — based on the number, size, and type of polyps.

Does Medicare cover colonoscopies after age 75 or 85? The colonoscopy benefit has no age cutoff. The 45–85 age range applies to Cologuard and blood-based tests, not colonoscopy. Whether screening still makes sense in your 80s is a clinical decision about health and life expectancy, not a coverage limit.

Is the bowel prep covered? Prescription preps are covered under your Part D plan, not the free screening benefit — generic large-volume preps typically cost $0–$10, low-volume branded kits more. Over-the-counter regimens aren’t covered but are inexpensive. Ask for the cheapest option on your formulary.

Colorectal cancer screening is the rare place in Medicare where the incentives, the medicine, and the money all point the same direction: the test is free, it prevents rather than detects, and the rules that used to generate surprise bills have been legislated away one by one. If you’re due — and one in three eligible adults is — the only expensive colonoscopy is the one you don’t get.